Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Zealand Pharma A/S (ZLDPF : OTC)

• Company Description    Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. The company's pipeline includes ZP4207, single-dose rescue treatment for acute, severe hypoglycemia; ZP1848 for short bowel syndrome and ZP4207, multiple-dose version intended for use in a dual-hormone artificial pancreas system for better hypoglycemia control and diabetes management and other earlier-stage clinical and preclinical peptide therapeutics are in clinical stage. Zealand Pharma A/S is based in Copenhagen, Denmark. Number of Employees: 481

• Price / Volume Information    Yesterday's Closing Price: $46.38 Daily Weekly Monthly 20 Day Moving Average: 989 shares Shares Outstanding: 71.53 (millions) Market Capitalization: $3,317.00 (millions) Beta: 0.89 52 Week High: $83.12 52 Week Low: $35.93 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -10.47% -9.16% 12 Week 3.03% 0.11% Year To Date -35.23% -41.94%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Sydmarken 11 Soborg - Copenhagen,G7 2860 DNK ph: 45-8877-3600 fax: 45-8877-3898 investors@zealandpharma.com http://www.zealandpharma.com

• General Corporate Information    Officers Adam Steensberg - Chief Executive Officer and President Martin Nicklasson - Chairman of the Board of Directors Ivan Moller - Executive Vice President;Chief Operating Officer Henriette Wennicke - Executive Vice President and Chief Financial Offic Bernadette Connaughton - Director Peer Information Zealand Pharma A/S (CORR.) Zealand Pharma A/S (RSPI) Zealand Pharma A/S (CGXP) Zealand Pharma A/S (BGEN) Zealand Pharma A/S (GTBP) Zealand Pharma A/S (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: K9898X127 SIC: 8880 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/12/26 Share - Related Items Shares Outstanding: 71.53 Most Recent Split Date: (:1) Beta: 0.89 Market Capitalization: $3,317.00 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.80 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $3.65 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/12/26

• Fundamental Ratios P/E Current FY Estimate: 12.70 Trailing 12 Months: 7.69 PEG Ratio: - Price Ratios Price/Book: 1.46 Price/Cash Flow: 3.36 Price / Sales: 4.59 EPS Growth vs. Year Ago Period: -46.39% vs. Previous Quarter: 1,089.66% Sales Growth vs. Year Ago Period: -49.45% vs. Previous Quarter: 13,017.07% ROE 06/30/26 - 18.53 03/31/26 - 41.80 12/31/25 - 48.10 ROA 06/30/26 - 17.14 03/31/26 - 38.49 12/31/25 - 43.91 Current Ratio 06/30/26 - - 03/31/26 - 37.17 12/31/25 - 23.57 Quick Ratio 06/30/26 - - 03/31/26 - 37.17 12/31/25 - 23.57 Operating Margin 06/30/26 - 58.86 03/31/26 - 68.82 12/31/25 - 70.06 Net Margin 06/30/26 - 58.86 03/31/26 - 68.82 12/31/25 - 70.06 Pre-Tax Margin 06/30/26 - - 03/31/26 - 74.39 12/31/25 - 75.98 Book Value 06/30/26 - - 03/31/26 - 31.68 12/31/25 - 31.61 Inventory Turnover 06/30/26 - - 03/31/26 - 0.17 12/31/25 - 0.16 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.02 12/31/25 - 0.02 Debt-to-Capital 06/30/26 - - 03/31/26 - 2.08 12/31/25 - 2.00

Powered by Zacks Investment Research ©